Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome-Reference-Cited by-同舟云学术

Tumor Size Differences Between Preoperative Endoscopic Ultrasound and Postoperative Pathology for Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma Predict Patient Outcome

Published:2020-12 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Das Rohit,McGrath Kevin,Seiser Natalie,Smith Katelyn,Uttam Shikhar,Brand Randall E.,Fasanella Kenneth E.,Khalid Asif,Chennat Jennifer S.,Sarkaria Savreet,Singh Harkirat,Slivka Adam,Zeh Herbert J.,Zureikat Amer H.,Hogg Melissa E.,Lee Kenneth K.,Paniccia Alessandro,Ongchin Melanie C.,Pingpank James F.,Boone Brian A.,Dasyam Anil K.,Bahary Nathan,Gorantla Vikram C.,Rhee John C.,Thomas Roby,Ellsworth Susannah,Landau Michael S.,Ohori N. Paul,Henn Patrick,Shyu Susan,Theisen Brian K.,Singhi Aatur D.^ORCID

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Neoadjuvant therapy for resectable pancreatic cancer: an evolving paradigm shift;Chawla;Front Oncol,2019

3. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery;Barnes;Surgery,2019

4. Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies;Zhan;Cancer Med,2017

5. Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patients;Dhir;World J Surg Oncol,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of occult metastases in potentially Resectable pancreatic ductal adenocarcinoma;Surgery Open Science;2024-08

2. Pancreatic mucinous adenocarcinoma has different clinical characteristics and better prognosis compared to non-specific PDAC: A retrospective observational study;Heliyon;2024-05

3. Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis;Journal of Clinical Medicine;2023-11-28

4. Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries;Frontiers in Endocrinology;2023-11-02

5. Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy;JAMA Surgery;2023-01-01